Accustem Sciences Inc. (ACUT)

USD 0.24

(0.0%)

Market Cap (In USD)

2.74 Million

Revenue (In USD)

-

Net Income (In USD)

-3.74 Million

Avg. Volume

2644.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.242-0.7246
PE
-
EPS
-
Beta Value
3.174
ISIN
US00444A1016
CUSIP
00444A101
CIK
1850767
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Wendy E. Blosser
Employee Count
-
Website
https://www.accustem.com
Ipo Date
2022-03-03
Details
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. The company is based in New York, New York.